Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis

NCT02339441 · clinicaltrials.gov ↗

COMPLETED

Status

320

Enrollment

OTHER

Sponsor class

Conditions

Early Diffuse Cutaneous Systemic Sclerosis

Interventions

DRUG: Methotrexate
DRUG: Mycophenolate mofetil
DRUG: Cyclophosphamide

Sponsor

University of Manchester